{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:48:45Z","timestamp":1782200925674,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.transci.2026.104402","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:32:12Z","timestamp":1769844732000},"page":"104402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The case against infusing ABO incompatible antibody and antigen from all blood components"],"prefix":"10.1016","volume":"65","author":[{"given":"Nicholas","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Masel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong-Lan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akua","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majed","family":"Refaai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Heal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transci.2026.104402_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21307\/immunohematology-2019-418","article-title":"Review: ABO blood group system\u2013ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Immunohematology"},{"issue":"1","key":"10.1016\/j.transci.2026.104402_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1182\/hematology.2020000135","article-title":"Does ABO and RhD matching matter for platelet transfusion?","volume":"2020","author":"Dunbar","year":"2020","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.transci.2026.104402_bib3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1213\/ANE.0000000000002600","article-title":"Is it time to reconsider the concepts of \"universal donor\" and \"ABO compatible\" transfusions?","volume":"126","author":"Refaai","year":"2018","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.transci.2026.104402_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/vox.12354","article-title":"ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion","volume":"110","author":"Zaffuto","year":"2016","journal-title":"Vox Sang"},{"issue":"12","key":"10.1016\/j.transci.2026.104402_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/biomedicines9121851","article-title":"Essential role of Rho-associated kinase in ABO immune complex-mediated endothelial barrier disruption","volume":"9","author":"McRae","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.transci.2026.104402_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/trf.13376","article-title":"Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood","volume":"56","author":"Pai","year":"2016","journal-title":"Transfusion"},{"issue":"11","key":"10.1016\/j.transci.2026.104402_bib7","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1111\/trf.16638","article-title":"Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood","volume":"61","author":"Parvizian","year":"2021","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.transci.2026.104402_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/trf.18135","article-title":"Associations between blood donors, component modifications, and the alloimmunization of transfusion recipients","volume":"65","author":"Yu","year":"2025","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.transci.2026.104402_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5858\/2007-131-909-TOPCAP","article-title":"Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories","volume":"131","author":"Fung","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.transci.2026.104402_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2023.103658","article-title":"Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: two case reports","volume":"62","author":"Zulkeflee","year":"2023","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.transci.2026.104402_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/tme.12938","article-title":"Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion","volume":"33","author":"Bienz","year":"2023","journal-title":"Transfus Med"},{"issue":"2","key":"10.1016\/j.transci.2026.104402_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.2830450219","article-title":"A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions","volume":"45","author":"Heal","year":"1994","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.transci.2026.104402_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1537-2995.1999.39299154733.x","article-title":"ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation","volume":"39","author":"Benjamin","year":"1999","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.transci.2026.104402_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1046\/j.1537-2995.2001.41060790.x","article-title":"Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery","volume":"41","author":"Blumberg","year":"2001","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.transci.2026.104402_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.htct.2020.06.011","article-title":"Transfusion of ABO non-identical platelets increases the severity of trauma patients at ICU admission","volume":"43","author":"Silva","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"issue":"3","key":"10.1016\/j.transci.2026.104402_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2141.1990.tb04356.x","article-title":"Transfusion of ABO-mismatched platelets leads to early platelet refractoriness","volume":"75","author":"Carr","year":"1990","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.transci.2026.104402_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-0609.1993.tb00150.x","article-title":"The role of ABO matching in platelet transfusion","volume":"50","author":"Heal","year":"1993","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.transci.2026.104402_bib18","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/bjh.19359","article-title":"ABO non-identical platelet transfusions, immune platelet refractoriness and platelet support","volume":"204","author":"Han","year":"2024","journal-title":"Br J Haematol"},{"issue":"19","key":"10.1016\/j.transci.2026.104402_bib19","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood.2020008381","article-title":"Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage","volume":"137","author":"Magid-Bernstein","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.transci.2026.104402_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01695973","article-title":"ABO and platelet transfusion revisited","volume":"66","author":"Heal","year":"1993","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.transci.2026.104402_bib21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/ijlh.14283","article-title":"Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies","volume":"46","author":"Wu","year":"2024","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.transci.2026.104402_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1423-0410.2009.01167.x","article-title":"Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma","volume":"96","author":"Shanwell","year":"2009","journal-title":"Vox Sang"},{"issue":"9","key":"10.1016\/j.transci.2026.104402_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.2010.175","article-title":"Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients","volume":"145","author":"Inaba","year":"2010","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.transci.2026.104402_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/ajts.ajts_83_21","article-title":"Effect of cryoprecipitate transfusion without ABO group consideration: a nightmare experience","volume":"16","author":"Sahoo","year":"2022","journal-title":"Asian J Transfus Sci"},{"issue":"9","key":"10.1016\/j.transci.2026.104402_bib25","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/vox.13330","article-title":"Practice patterns of ABO-matching for cryoprecipitate and patient outcomes after ABO-compatible versus incompatible cryoprecipitate","volume":"117","author":"Raycraft","year":"2022","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.transci.2026.104402_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1423-0410.2010.01464.x","article-title":"An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients","volume":"101","author":"Refaai","year":"2011","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.transci.2026.104402_bib27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1537-2995.2011.03329.x","article-title":"Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence","volume":"52","author":"Henrichs","year":"2012","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.transci.2026.104402_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.humimm.2009.03.001","article-title":"Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products","volume":"70","author":"Coppage","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transci.2026.104402_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2017.09.011","article-title":"ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia","volume":"62","author":"Sahai","year":"2017","journal-title":"Leuk Res"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:18:16Z","timestamp":1782199096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1473050226000340"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104402","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The case against infusing ABO incompatible antibody and antigen from all blood components","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104402"}}